Pancreatic Cancer Research

ResearcherWest China Hospital of Sichuan UniversityActive in the last 2 years

Zhihong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5779-9365; OpenAlex author ID A5100419466. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. First author DOI 10.4149/gpb_2024047↗
  2. LINC01133 promotes pancreatic ductal adenocarcinoma epithelial-mesenchymal transition mediated by SPP1 through binding to Arp3. Last author DOI 10.1038/s41419-024-06876-3↗
  3. Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer. Co-author DOI 10.1016/j.jncc.2022.08.006↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiayun Ge · 1 shared paper, 2025 · strength 0.27
  2. Bo Tang · 1 shared paper, 2025 · strength 0.27
  3. Renchao Zou · 1 shared paper, 2025 · strength 0.27
  4. Xin Wang · 1 shared paper, 2025 · strength 0.27
  5. Yefan Yang · 1 shared paper, 2024 · strength 0.24
  6. Feng Jiao · 1 shared paper, 2022 · strength 0.09
  7. Zheng Wang · 1 shared paper, 2022 · strength 0.09
  8. Zhiwei Li · 1 shared paper, 2022 · strength 0.09
  9. Tao Zhang · 1 shared paper, 2022 · strength 0.09
  10. Qingyong Ma · 1 shared paper, 2022 · strength 0.09
  11. Liwei Wang · 1 shared paper, 2022 · strength 0.09
  12. Chunyi Hao · 1 shared paper, 2022 · strength 0.09
  13. Gang Ren · 1 shared paper, 2022 · strength 0.09
  14. Jie Chen · 1 shared paper, 2022 · strength 0.09
  15. Dan Cao · 1 shared paper, 2022 · strength 0.09
  16. Jian Wang · 1 shared paper, 2022 · strength 0.09
  17. Yongrui Bai · 1 shared paper, 2022 · strength 0.09
  18. Yongwei Sun · 1 shared paper, 2022 · strength 0.09
  19. Ji Li · 1 shared paper, 2022 · strength 0.09
  20. Jianping Xiong · 1 shared paper, 2022 · strength 0.09
  21. Jun Zhou · 1 shared paper, 2022 · strength 0.09
  22. Feng‐Hua Wang · 1 shared paper, 2022 · strength 0.09
  23. Leizhen Zheng · 1 shared paper, 2022 · strength 0.09
  24. Da Li · 1 shared paper, 2022 · strength 0.09
  25. Chengfeng Wang · 1 shared paper, 2022 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.